Aromatase-IN-2 (Cat No.: I042477) is a synthetic small-molecule inhibitor targeting aromatase, the enzyme responsible for converting androgens into estrogens. By blocking this conversion, Aromatase-IN-2 reduces estrogen levels, making it a promising candidate for hormone-dependent cancer therapies, particularly estrogen receptor-positive (ER+) breast cancer. It is under investigation for its potency, selectivity, and pharmacokinetics in preclinical studies. Aromatase-IN-2 may also be explored for other estrogen-related conditions, offering potential benefits in managing diseases where estrogen suppression is therapeutically advantageous.